Skip to main content
. 2023 May 8;108(10):e923–e936. doi: 10.1210/clinem/dgad255

Table 2.

Effects of antidiabetic drugs on bone turnover, bone mineral density, and fracture risk (6, 61)

Bone turnover marker BMD Fracture risk
Bone formation Bone resorption
Metformin ↓/∼ ↓/∼ ∼/↑ ↓/∼
Sulfonylureas ↑/∼ ↓/∼ ND ↓/∼/↑
Thiazolidinediones ↓↓/∼/↑ ↑↑/∼ ↓↓/∼ ↑↑
GLP-1 analogues ↓↓ ↑/∼
DPP4 inhibitors ↓/∼ ∼/↓
SGLT2 inhibitors ∼/↑ ∼/↑
Insulin

Abbreviations: ↑∣increased; ↓∣decreased; ∼∣unchanged; BMD, bone mineral density; DPP4, dipeptidyl peptidase inhibitor 4; GLP1, glucagon-like peptide 1; ND, not determined; SGLT2, sodium/glucose cotransporter 2.